Flora Growth Corp. Applauds Senator Wyden for Introducing the Cannabinoid Safety and Regulations Act
Flora Growth Corp. (NASDAQ: FLGC) has expressed strong support for the Cannabinoid Safety and Regulations Act introduced by U.S. Senator Ron Wyden. This landmark legislation aims to establish a comprehensive framework for the safe production, labeling, and marketing of cannabinoid products to adults, with strict measures to prevent access by children.
The bill has gained backing from key industry organizations, including the U.S. Hemp Roundtable and the National Cannabis Industry Association. Flora's CEO, Clifford Starke, emphasized that the act represents a important step forward for the cannabis and hemp industries, creating a robust legal pathway for companies to deliver safe, high-quality cannabinoid products while ensuring rigorous testing, proper labeling, and age restrictions.
The proposed legislation addresses the growing demand for hemp-derived cannabinoid products like CBD and Delta-8 THC, establishing requirements for testing, labeling, and responsible marketing. Flora believes this bill will foster a more secure environment for businesses and consumers by providing clear regulations for the production and distribution of cannabinoid products.
Flora Growth Corp. (NASDAQ: FLGC) ha espresso un forte sostegno per il Cannabinoid Safety and Regulations Act introdotto dal Senatore statunitense Ron Wyden. Questa legislazione storica mira a stabilire un quadro completo per la produzione, l'etichettatura e il marketing sicuri dei prodotti a base di cannabinoidi per gli adulti, con misure rigorose per prevenire l'accesso da parte dei minori.
Il disegno di legge ha ricevuto il sostegno di importanti organizzazioni del settore, tra cui l'U.S. Hemp Roundtable e la National Cannabis Industry Association. Il CEO di Flora, Clifford Starke, ha sottolineato che la legge rappresenta un passo importante per le industrie della cannabis e della canapa, creando un solido percorso legale per le aziende per offrire prodotti a base di cannabinoidi sicuri e di alta qualità, garantendo al contempo test rigorosi, etichettatura adeguata e restrizioni di età.
La legge proposta affronta la crescente domanda di prodotti contenenti cannabinoidi derivati dalla canapa, come il CBD e il Delta-8 THC, stabilendo requisiti per test, etichettatura e marketing responsabile. Flora ritiene che questo disegno di legge favorirà un ambiente più sicuro per le imprese e i consumatori fornendo regolamenti chiari per la produzione e la distribuzione di prodotti a base di cannabinoidi.
Flora Growth Corp. (NASDAQ: FLGC) ha expresado un fuerte apoyo a la Cannabinoid Safety and Regulations Act presentada por el senador estadounidense Ron Wyden. Esta legislación histórica tiene como objetivo establecer un marco integral para la producción, etiquetado y comercialización segura de productos de cannabinoides para adultos, con medidas estrictas para prevenir el acceso de niños.
El proyecto de ley ha recibido el respaldo de importantes organizaciones de la industria, incluyendo el U.S. Hemp Roundtable y la National Cannabis Industry Association. El CEO de Flora, Clifford Starke, enfatizó que la ley representa un paso importante hacia adelante para las industrias del cannabis y el cáñamo, creando un sólido camino legal para que las empresas ofrezcan productos de cannabinoides seguros y de alta calidad, asegurando a su vez pruebas rigurosas, etiquetado adecuado y restricciones de edad.
La legislación propuesta aborda la creciente demanda de productos de cannabinoides derivados del cáñamo, como el CBD y el Delta-8 THC, estableciendo requisitos para pruebas, etiquetado y marketing responsable. Flora cree que este proyecto de ley fomentará un entorno más seguro para las empresas y los consumidores, al proporcionar regulaciones claras para la producción y distribución de productos de cannabinoides.
플로라 그로스 코퍼레이션(Flora Growth Corp. NASDAQ: FLGC)은 미국 상원 의원 론 와이든(Ron Wyden)이 제안한 대마초 안전 및 규제 법안(Cannabinoid Safety and Regulations Act)에 강력히 지지한다고 밝혔습니다. 이 역사적인 법안은 성인이 사용할 수 있는 대마초 제품의 안전한 생산, 라벨링 및 마케팅을 위한 포괄적인 법적 틀을 수립하는 것을 목표로 하며, 어린이의 접근을 방지하기 위한 엄격한 조치를 가집니다.
이 법안은 미국 햄프 라운드테이블(U.S. Hemp Roundtable) 및 국가 대마초 산업 협회(National Cannabis Industry Association)와 같은 주요 산업 단체의 지지를 받았습니다. 플로라의 CEO인 클리포드 스타크(Clifford Starke)는 이 법안이 대마초 및 대마 산업의 중요한 진전을 나타내며, 기업이 안전하고 고품질의 대마초 제품을 제공할 수 있도록 강력한 법적 경로를 만들 것이라고 강조했습니다. 이는 철저한 테스트, 적절한 라벨링 및 연령 제한을 보장합니다.
제안된 법안은 CBD 및 Delta-8 THC와 같은 헴프 유래 대마초 제품에 대한 증가하는 수요를 해결하며, 테스트, 라벨링 및 책임 있는 마케팅에 대한 요구 사항을 수립합니다. 플로라는 이 법안이 대마초 제품의 생산 및 유통에 대한 명확한 규정을 제공하여 기업 및 소비자에게 보다 안전한 환경을 조성할 것이라고 믿고 있습니다.
Flora Growth Corp. (NASDAQ: FLGC) a exprimé son fort soutien à la loi sur la sécurité et la réglementation des cannabinoïdes introduite par le sénateur américain Ron Wyden. Cette législation historique vise à établir un cadre complet pour la production, l'étiquetage et la commercialisation sûrs des produits cannabinoïdes pour les adultes, avec des mesures strictes pour empêcher l'accès des enfants.
Le projet de loi a reçu le soutien d'organisations clés de l'industrie, y compris l'U.S. Hemp Roundtable et la National Cannabis Industry Association. Le PDG de Flora, Clifford Starke, a souligné que cette loi représente un pas important en avant pour les industries du cannabis et du chanvre, créant un chemin légal solide pour que les entreprises puissent offrir des produits cannabinoïdes sûrs et de haute qualité tout en garantissant des tests rigoureux, un étiquetage adéquat et des restrictions d'âge.
La législation proposée aborde la demande croissante de produits cannabinoïdes dérivés du chanvre, tels que le CBD et le Delta-8 THC, en établissant des exigences pour les tests, l'étiquetage et le marketing responsable. Flora croit que ce projet de loi favorisera un environnement plus sécurisé pour les entreprises et les consommateurs en fournissant des réglementations claires pour la production et la distribution de produits cannabinoïdes.
Flora Growth Corp. (NASDAQ: FLGC) hat eine starke Unterstützung für das von dem US-Senator Ron Wyden eingeführte Cannabinoid Safety and Regulations Act ausgesprochen. Diese wegweisende Gesetzgebung zielt darauf ab, einen umfassenden Rahmen für die sichere Produktion, Kennzeichnung und Vermarktung von Cannabinoidprodukten für Erwachsene zu schaffen, mit strengen Maßnahmen, um den Zugang für Kinder zu verhindern.
Der Vorschlag hat Rückhalt von wichtigen Branchenorganisationen erhalten, darunter das U.S. Hemp Roundtable und die National Cannabis Industry Association. Der CEO von Flora, Clifford Starke, betonte, dass das Gesetz einen wichtigen Schritt nach vorne für die Cannabis- und Hanfindustrien bedeutet und einen soliden rechtlichen Weg für Unternehmen schafft, um sichere, hochwertige Cannabinoidprodukte anzubieten und gleichzeitig rigorose Tests, eine ordnungsgemäße Kennzeichnung und Altersbeschränkungen sicherzustellen.
Die vorgeschlagene Gesetzgebung spricht die wachsende Nachfrage nach hanf-basierten Cannabinoidprodukten wie CBD und Delta-8 THC an und legt Anforderungen für Tests, Kennzeichnung und verantwortungsbewusste Vermarktung fest. Flora ist der Meinung, dass dieses Gesetz ein sichereres Umfeld für Unternehmen und Verbraucher fördern wird, indem klare Vorschriften für die Produktion und den Vertrieb von Cannabinoidprodukten bereitgestellt werden.
- Potential for clearer regulatory framework in the cannabinoid industry
- Possible expansion of legal pathways for cannabinoid product sales
- Increased safety standards may boost consumer confidence in Flora's products
- Potential increased compliance costs to meet new regulatory standards
- Possible market restrictions if certain products fail to meet new safety criteria
Fort Lauderdale, Florida--(Newsfile Corp. - September 25, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") today commended U.S. Senator Ron Wyden for introducing the Cannabinoid Safety and Regulations Act. This landmark piece of legislation is aimed at establishing a comprehensive framework to ensure cannabinoid products are safely produced, labeled, and marketed to adults, with stringent safeguards to keep these products out of the hands of children. The bill has garnered widespread support from key industry organizations, including the U.S. Hemp Roundtable, the National Cannabis Industry Association, the National Industrial Hemp Council, and hemp industry associations across several states.
Clifford Starke, Chairman and Chief Executive Officer, expressed the Company's full support for the bill and its commitment to responsible regulation in the cannabinoid sector, "The introduction of the Cannabinoid Safety and Regulation Act represents a pivotal step forward for the cannabis and hemp industries. By establishing clear regulatory standards, this bill will not only protect public health and safety but also create a robust legal pathway for companies like Flora to deliver safe, high-quality cannabinoid products to adults. Importantly, it ensures that these products are rigorously tested, properly labeled, and age-restricted," said Mr. Starke.
The Cannabinoid Safety and Regulation Act proposes a legal framework that addresses the growing demand for hemp-derived cannabinoid products, such as CBD, Delta-8 THC, and other compounds, by establishing requirements for testing, labeling, and responsible marketing. It also provides much-needed clarity and safety measures for the industry while protecting consumers.
Flora remains committed to advancing the cannabis and hemp industries through high standards of quality, safety, and compliance. The Company believes that this bill will create a more secure environment for both businesses and consumers by providing clear regulations for the production and distribution of cannabinoid products.
"The endorsement of this bill by such a wide spectrum of respected industry organizations is a testament to its importance and impact. We fully support this bill and encourage lawmakers to pass it swiftly to promote a safer, more transparent marketplace for cannabinoid products," concluded Mr. Starke.
About Flora Growth Corp.
Flora Growth Corp.'s mission is to become the leading NASDAQ small-cap international cannabis company. FLGC is a consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world. For more information on Flora, visit www.floragrowth.com.
https://justcbdstore.com/
https://www.vesselbrand.com/
https://justcbdstore.uk/
https://www.phatebo.de/home-en
https://www.australianvaporizers.com.au/
Investor Relations:
Investor Relations ir@floragrowth.com
Clifford Starke Clifford.Starke@floragrowth.com
Media:
Cautionary Statement Concerning Forward-Looking Statements
This press release contains "forward-looking statements," as defined by U.S. federal securities laws. Forward-looking statements reflect Flora's current expectations and projections about future events at the time, and thus involve uncertainty and risk. The words "believe," "expect," "anticipate," "will," "could," "would," "should," "may," "plan," "estimate," "intend," "predict," "potential," "continue," and the negatives of these words and other similar expressions generally identify forward-looking statements. Such forward-looking statements are subject to various and risks and uncertainties, including those described under section entitled "Risk Factors" in Flora's Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (the "SEC") on March 28, 2024, as such factors may be updated from time to time in Flora's periodic filings with the SEC, which are accessible on the SEC's website at www.sec.gov/edgar. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this release and in Flora's filings with the SEC. While forward-looking statements reflect Flora's good faith beliefs, they are not guarantees of future performance. Flora disclaims any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, new information, data or methods, future events or other changes after the date of this press release, except as required by applicable law. You should not place undue reliance on any forward-looking statements, which are based on information currently available to Flora (or to third parties making the forward-looking statements).
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/224598
FAQ
What is the Cannabinoid Safety and Regulations Act introduced by Senator Wyden?
How does Flora Growth Corp. (FLGC) view the proposed Cannabinoid Safety and Regulations Act?
What potential impact could the Cannabinoid Safety and Regulations Act have on Flora Growth Corp. (FLGC)?
